Literature DB >> 2026742

Effect of recombinant activin on androgen synthesis in cultured human thecal cells.

S G Hillier1, E L Yong, P J Illingworth, D T Baird, R H Schwall, A J Mason.   

Abstract

The effect of activin-A on ovarian androgen synthesis was tested in vitro using serum-free monolayer cultures of human thecal cells. Maximal rates of androgen (androstenedione and dehydroepiandrosterone) production were induced by treating the cells for 4 days with LH (10 ng/mL) in the presence of insulin-like growth factor-I (greater than or equal to 30 ng/mL). The additional presence of recombinant activin-A (1-100 ng/mL) in culture medium caused dose-dependent suppression of thecal cell androgen production, with 50% maximal inhibition occurring at an activin-A concentration of about 10 ng/mL. Progesterone production was only suppressed by high dose (100 ng/mL) activin-A, and inhibition of steroid production occurred without inhibition of DNA synthesis (tritiated thymidine uptake). These results reveal a potent and selective inhibitory action of activin-A on thecal cell androgen synthesis, consistent with a paracrine function for activin(s) in modulating follicular androgen biosynthesis in the human ovary.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026742     DOI: 10.1210/jcem-72-6-1206

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  The ovarian androgen-producing cells: a 2001 perspective.

Authors:  Denis A Magoffin
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

2.  Luteal-phase inhibin A and follicular-phase inhibin B levels are not characteristic of patients with an elevated LH-to-FSH ratio.

Authors:  Erik E Hauzman; Péter Fancsovits; Akos Murber; Thomas Rabe; Thomas Strowitzki; Zoltán Papp; János Urbancsek
Journal:  J Assist Reprod Genet       Date:  2006-03       Impact factor: 3.412

Review 3.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

4.  Cryptotanshinone reverses reproductive disturbances in rats with dehydroepiandrosterone-induced polycystic ovary syndrome.

Authors:  Yanqiu Xia; Pei Zhao; Hongli Huang; Yuan Xie; Rong Lu; Li Dong
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

5.  Paracrine regulation of theca androgen production by granulosa cells in the ovary.

Authors:  Yvonne D Hoang; Kirsten J McTavish; R Jeffrey Chang; Shunichi Shimasaki
Journal:  Fertil Steril       Date:  2013-05-23       Impact factor: 7.329

Review 6.  The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies.

Authors:  R B Barnes
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

7.  Testicular somatic cells, not gonocytes, are the major source of functional activin A during testis morphogenesis.

Authors:  Denise R Archambeault; Jessica Tomaszewski; Andrew J Childs; Richard A Anderson; Humphrey Hung-Chang Yao
Journal:  Endocrinology       Date:  2011-09-27       Impact factor: 4.736

8.  The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women.

Authors:  Leif Bungum; Florencia Franssohn; Mona Bungum; Peter Humaidan; Aleksander Giwercman
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

9.  Inhibin removes the inhibitory effects of activin on steroid enzyme expression and androgen production by normal ovarian thecal cells.

Authors:  J M Young; A S McNeilly
Journal:  J Mol Endocrinol       Date:  2012-01-25       Impact factor: 5.098

10.  Regulation and 3 dimensional culture of tertiary follicle growth.

Authors:  Yong-Pil Cheon
Journal:  Clin Exp Reprod Med       Date:  2012-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.